These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
435 related articles for article (PubMed ID: 28187494)
1. The fecal hemoglobin concentration, age and sex test score: Development and external validation of a simple prediction tool for colorectal cancer detection in symptomatic patients. Cubiella J; Digby J; Rodríguez-Alonso L; Vega P; Salve M; Díaz-Ondina M; Strachan JA; Mowat C; McDonald PJ; Carey FA; Godber IM; Younes HB; Rodriguez-Moranta F; Quintero E; Álvarez-Sánchez V; Fernández-Bañares F; Boadas J; Campo R; Bujanda L; Garayoa A; Ferrandez Á; Piñol V; Rodríguez-Alcalde D; Guardiola J; Steele RJ; Fraser CG; Int J Cancer; 2017 May; 140(10):2201-2211. PubMed ID: 28187494 [TBL] [Abstract][Full Text] [Related]
2. Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients. Cubiella J; Vega P; Salve M; Díaz-Ondina M; Alves MT; Quintero E; Álvarez-Sánchez V; Fernández-Bañares F; Boadas J; Campo R; Bujanda L; Clofent J; Ferrandez Á; Torrealba L; Piñol V; Rodríguez-Alcalde D; Hernández V; Fernández-Seara J; BMC Med; 2016 Aug; 14(1):128. PubMed ID: 27580745 [TBL] [Abstract][Full Text] [Related]
3. Symptom or faecal immunochemical test based referral criteria for colorectal cancer detection in symptomatic patients: a diagnostic tests study. Herrero JM; Vega P; Salve M; Bujanda L; Cubiella J BMC Gastroenterol; 2018 Oct; 18(1):155. PubMed ID: 30359225 [TBL] [Abstract][Full Text] [Related]
4. A New-Generation Fecal Immunochemical Test (FIT) Is Superior to Quaiac-based Test in Detecting Colorectal Neoplasia Among Colonoscopy Referral Patients. Vasilyev S; Smirnova E; Popov D; Semenov A; Eklund C; Hendolin P; Paloheimo L; Syrjänen K Anticancer Res; 2015 May; 35(5):2873-80. PubMed ID: 25964570 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy of the faecal immunochemical test for colorectal cancer in symptomatic patients: comparison with NICE and SIGN referral criteria. Cubiella J; Salve M; Díaz-Ondina M; Vega P; Alves MT; Iglesias F; Sánchez E; Macía P; Blanco I; Bujanda L; Fernández-Seara J Colorectal Dis; 2014 Aug; 16(8):O273-82. PubMed ID: 24456168 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic Accuracy of a Qualitative Fecal Immunochemical Test Varies With Location of Neoplasia But Not Number of Specimens. Wong MC; Ching JY; Chan VC; Lam TY; Shum JP; Luk AK; Wong SS; Ng SC; Ng SS; Wu JC; Chan FK; Sung JJ Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1472-9. PubMed ID: 25724708 [TBL] [Abstract][Full Text] [Related]
7. Use of a faecal immunochemical test for haemoglobin can aid in the investigation of patients with lower abdominal symptoms. Godber IM; Todd LM; Fraser CG; MacDonald LR; Younes HB Clin Chem Lab Med; 2016 Apr; 54(4):595-602. PubMed ID: 26457785 [TBL] [Abstract][Full Text] [Related]
8. Risk stratification for advanced colorectal neoplasia according to fecal hemoglobin concentration in a colorectal cancer screening program. Auge JM; Pellise M; Escudero JM; Hernandez C; Andreu M; Grau J; Buron A; López-Cerón M; Bessa X; Serradesanferm A; Piracés M; Macià F; Guayta R; Filella X; Molina R; Jimenez W; Castells A; Gastroenterology; 2014 Sep; 147(3):628-636.e1. PubMed ID: 24937264 [TBL] [Abstract][Full Text] [Related]
9. Fecal immunochemical test accuracy in familial risk colorectal cancer screening. Castro I; Cubiella J; Rivera C; González-Mao C; Vega P; Soto S; Hernandez V; Iglesias F; Teresa Alves M; Bujanda L; Fernández-Seara J Int J Cancer; 2014 Jan; 134(2):367-75. PubMed ID: 23818169 [TBL] [Abstract][Full Text] [Related]
10. Association of time to colonoscopy after a positive fecal test result and fecal hemoglobin concentration with risk of advanced colorectal neoplasia. Kim NH; Lim JW; Kim S; Lim JY; Kim W; Park JH; Park DI; Sohn CI; Jung YS Dig Liver Dis; 2019 Apr; 51(4):589-594. PubMed ID: 30733186 [TBL] [Abstract][Full Text] [Related]
11. Gender Differences in Fecal Immunochemical Test Performance for Early Detection of Colorectal Neoplasia. Kapidzic A; van der Meulen MP; Hol L; van Roon AH; Looman CW; Lansdorp-Vogelaar I; van Ballegooijen M; van Vuuren AJ; Reijerink JC; van Leerdam ME; Kuipers EJ Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1464-71.e4. PubMed ID: 25724706 [TBL] [Abstract][Full Text] [Related]
12. Effects of Increasing Screening Age and Fecal Hemoglobin Cutoff Concentrations in a Colorectal Cancer Screening Program. Wieten E; Schreuders EH; Nieuwenburg SA; Hansen BE; Lansdorp-Vogelaar I; Kuipers EJ; Bruno MJ; Spaander MC Clin Gastroenterol Hepatol; 2016 Dec; 14(12):1771-1777. PubMed ID: 27567693 [TBL] [Abstract][Full Text] [Related]
13. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening. Quintero E; Carrillo M; Gimeno-García AZ; Hernández-Guerra M; Nicolás-Pérez D; Alonso-Abreu I; Díez-Fuentes ML; Abraira V Gastroenterology; 2014 Nov; 147(5):1021-30.e1; quiz e16-7. PubMed ID: 25127679 [TBL] [Abstract][Full Text] [Related]
14. Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia. de Wijkerslooth TR; Stoop EM; Bossuyt PM; Meijer GA; van Ballegooijen M; van Roon AH; Stegeman I; Kraaijenhagen RA; Fockens P; van Leerdam ME; Dekker E; Kuipers EJ Am J Gastroenterol; 2012 Oct; 107(10):1570-8. PubMed ID: 22850431 [TBL] [Abstract][Full Text] [Related]
15. Faecal haemoglobin can define risk of colorectal neoplasia at surveillance colonoscopy in patients at increased risk of colorectal cancer. Digby J; Cleary S; Gray L; Datt P; Goudie DR; Steele RJC; Strachan JA; Humphries A; Fraser CG; Mowat C United European Gastroenterol J; 2020 Jun; 8(5):559-566. PubMed ID: 32213041 [TBL] [Abstract][Full Text] [Related]
16. Impact of age- and gender-specific cut-off values for the fecal immunochemical test for hemoglobin in colorectal cancer screening. Alvarez-Urturi C; Andreu M; Hernandez C; Perez-Riquelme F; Carballo F; Ono A; Cruzado J; Cubiella J; Hernandez V; Mao CG; Perez E; Salas D; Andrés M; Bujanda L; Portillo I; Sarasqueta C; Quintero E; Morillas JD; Lanas A; Sostres C; Augé JM; Castells A; Bessa X; Dig Liver Dis; 2016 May; 48(5):542-551. PubMed ID: 26936343 [TBL] [Abstract][Full Text] [Related]
17. Demand for Colonoscopy in Colorectal Cancer Screening Using a Quantitative Fecal Immunochemical Test and Age/Sex-Specific Thresholds for Test Positivity. Chen SL; Hsu CY; Yen AM; Young GP; Chiu SY; Fann JC; Lee YC; Chiu HM; Chiou ST; Chen HH Cancer Epidemiol Biomarkers Prev; 2018 Jun; 27(6):704-709. PubMed ID: 29593012 [No Abstract] [Full Text] [Related]
18. Association Between Colorectal Cancer Mortality and Gradient Fecal Hemoglobin Concentration in Colonoscopy Noncompliers. Lee YC; Li-Sheng Chen S; Ming-Fang Yen A; Yueh-Hsia Chiu S; Ching-Yuan Fann J; Chuang SL; Chiang TH; Chou CK; Chiu HM; Wu MS; Wu CY; Chia SL; Chiou ST; Chen HH J Natl Cancer Inst; 2017 May; 109(5):. PubMed ID: 28376228 [TBL] [Abstract][Full Text] [Related]
19. Faecal occult blood loss accurately predicts future detection of colorectal cancer. A prognostic model. Meester RGS; van de Schootbrugge-Vandermeer HJ; Breekveldt ECH; de Jonge L; Toes-Zoutendijk E; Kooyker A; Nieboer D; Ramakers CR; Spaander MCW; van Vuuren AJ; Kuipers EJ; van Kemenade FJ; Nagtegaal ID; Dekker E; van Leerdam ME; Lansdorp-Vogelaar I; Gut; 2023 Jan; 72(1):101-108. PubMed ID: 35537811 [TBL] [Abstract][Full Text] [Related]
20. Quantile-based fecal hemoglobin concentration for assessing colorectal neoplasms with 1,263,717 Taiwanese screenees. Peng SM; Chiu HM; Jen HH; Hsu CY; Chen SL; Chiu SY; Yen AM; Fann JC; Lee YC; Chen HH BMC Med Inform Decis Mak; 2019 May; 19(1):94. PubMed ID: 31046760 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]